Poseida Therapeutics
Latest round
- Series D
Last raised
- Jun 2020
Total raised
- $284M
Investors
- 13
About Poseida Therapeutics
Founded in 2014 and headquartered in San Diego, US, Poseida Therapeutics, Inc. specializes in genetic engineering technologies. The company has undergone a significant business pivot towards advanced gene therapies. Poseida has a total of 10 deals recorded, with its most recent deal occurring on July 9, 2020.Poseida Therapeutics focuses on pioneering genetic engineering technologies to address life-threatening cancers and genetic diseases. Their core product offerings include the non-viral piggyBac® DNA Delivery System, which facilitates the insertion of large genetic payloads into various genomes, and the Cas-CLOVER™ Site-Specific Gene Editing System, designed for precise genetic modifications such as deletions, insertions, and knock-ins across multiple cell types. These technologies serve as the foundation for advancing allogeneic CAR-T therapies aimed at enhancing patient outcomes in oncology and for the potential development of functional cures for rare genetic disorders.Poseida Therapeutics generated revenue of USD 130,492,000 in the most recent year, 2022, with an EBITDA of USD -56,549,000 for the same period. The company generates revenue through strategic partnerships and collaborations with pharmaceutical firms and research institutions, focusing on the commercialization of its gene editing technologies and therapies. These initiatives are anticipated to enhance operational capabilities and accelerate the commercialization of their innovative genetic solutions.
Who invested in Poseida Therapeutics
13 investors across 4 rounds
See all investors in Poseida Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Poseida Therapeutics
Who invested in Poseida Therapeutics?
Poseida Therapeutics has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Poseida Therapeutics raised?
Poseida Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Poseida Therapeutics last raise money?
Poseida Therapeutics's most recent round on record is a Series D, in Jun 2020.
What does Poseida Therapeutics do?
Founded in 2014 and headquartered in San Diego, US, Poseida Therapeutics, Inc.
Where is Poseida Therapeutics headquartered?
Poseida Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Poseida Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Poseida Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Poseida Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.